Stockscreener 앱 받기
293.44
0.16%
0.47
시간 외 거래:
293.44
전일 마감가:
$292.97
열려 있는:
$292.615
하루 거래량:
678.43K
Relative Volume:
0.46
시가총액:
$56.88B
수익:
$310.23B
순이익/손실:
$1.69B
주가수익비율:
34.04
EPS:
8.62
순현금흐름:
$3.58B
1주 성능:
-1.47%
1개월 성능:
+0.11%
6개월 성능:
+18.35%
1년 성능:
+30.85%
1일 변동 폭
$292.34
$293.44
1주일 범위
$289.47
$297.07
52주 변동 폭
$218.65
$309.35
Cencora Inc Stock (COR) Company Profile
명칭
Cencora Inc
전화
610-727-7000
주소
1 WEST FIRST AVENUE, CONSHOHOCKEN
COR을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
COR
Cencora Inc
|
293.44 | 56.78B | 310.23B | 1.69B | 3.58B | 8.62 |
|
MCK
Mckesson Corporation
|
714.00 | 88.62B | 359.05B | 3.30B | 5.23B | 25.83 |
|
CAH
Cardinal Health Inc
|
157.76 | 37.50B | 222.29B | 1.56B | 2.44B | 6.41 |
|
HSIC
Henry Schein Inc
|
74.19 | 9.03B | 12.50B | 314.00M | 421.00M | 2.44 |
|
AHG
Akso Health Group Adr
|
1.92 | 793.65M | 2.22M | -5.63M | -1.68M | -0.24 |
Cencora Inc Stock (COR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-06-03 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2024-12-04 | 재개 | Mizuho | Outperform |
| 2024-09-18 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2024-02-26 | 개시 | Leerink Partners | Outperform |
| 2024-01-03 | 개시 | Barclays | Overweight |
| 2023-12-14 | 개시 | Wells Fargo | Equal Weight |
| 2023-03-31 | 개시 | Citigroup | Buy |
| 2023-01-31 | 재개 | Evercore ISI | Outperform |
| 2022-10-11 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2022-08-22 | 재개 | Morgan Stanley | Equal-Weight |
| 2022-07-11 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2022-06-07 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2022-05-26 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2022-04-12 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2022-04-01 | 재개 | Credit Suisse | Outperform |
| 2021-03-12 | 재개 | Evercore ISI | In-line |
| 2021-02-04 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2021-02-02 | 업그레이드 | Cowen | Market Perform → Outperform |
| 2021-01-06 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2021-01-06 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2020-12-10 | 다운그레이드 | Wells Fargo | Equal Weight → Underweight |
| 2020-12-03 | 개시 | Mizuho | Neutral |
| 2020-08-06 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2020-07-15 | 개시 | Barclays | Underweight |
| 2020-06-15 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2020-04-23 | 재개 | Credit Suisse | Outperform |
| 2020-04-16 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2020-04-13 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2020-04-01 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2020-03-17 | 업그레이드 | Citigroup | Neutral → Buy |
| 2020-02-11 | 다운그레이드 | BofA/Merrill | Buy → Underperform |
| 2020-02-07 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2019-09-12 | 개시 | Deutsche Bank | Hold |
| 2019-07-10 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2019-04-11 | 개시 | Guggenheim | Buy |
| 2019-04-10 | 다운그레이드 | BofA/Merrill | Buy → Underperform |
| 2019-04-10 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2019-02-11 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2019-01-17 | 개시 | UBS | Buy |
| 2018-12-10 | 다운그레이드 | Jefferies | Buy → Hold |
| 2018-10-26 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2018-09-20 | 개시 | Berenberg | Buy |
| 2018-07-17 | 재개 | Stifel | Hold |
| 2018-04-09 | 개시 | MoffettNathanson | Buy |
| 2018-03-12 | 업그레이드 | KeyBanc Capital Mkts | Sector Weight → Overweight |
| 2018-03-12 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2017-09-25 | 개시 | JP Morgan | Neutral |
| 2017-09-22 | 개시 | William Blair | Outperform |
모두보기
Cencora Inc 주식(COR)의 최신 뉴스
Is Cencora Inc. a good long term investmentExplosive trading opportunities - jammulinksnews.com
Cencora Inc. Stock Analysis and ForecastMarket-beating performance - jammulinksnews.com
What analysts say about Cencora Inc. stockFree Advanced Stock Screener Access - Autocar Professional
Here's What to Expect From Cencora's Next Earnings Report - MSN
What drives Cencora Inc. stock priceHigh-yield growth strategies - jammulinksnews.com
Why Cencora Inc. stock is on top investor watchlistsShort Squeeze Radar - beatles.ru
Cencora Slumps to 447th in Market Rankings as Trading Volume Drops 40.48 Percent - AInvest
Here's Why You Should Add Cencora Stock to Your Portfolio Now - MSN
Cencora Surges to 261st in Daily Rankings with 3.90 Billion Trading Volume - AInvest
Citius Oncology Expands Distribution Network for LYMPHIR with Execution of Distribution Services Agreement with Cencora - BioSpace
Cencora (COR) Partners With Citius Oncology For Immunotherapy Distribution Expansion - simplywall.st
Citius Oncology Expands Lymphir Distribution With Cencora - MarketScreener
Citius Oncology expands distribution network for LYMPHIR with Cencora - Investing.com Australia
Citius stock gains on Cencora distribution deal (CTXR:NASDAQ) - Seeking Alpha
Citius Oncology expands distribution network for LYMPHIR with Cencora By Investing.com - Investing.com Nigeria
Lobbying Update: $20,000 of CENCORA INC. (FORMERLY AMERISOURCEBERGEN CORPORATION) lobbying was just disclosed - Quiver Quantitative
Cencora, Inc. (COR): If It Was Down, I’d Say “Double Down And Buy,” Says Jim Cramer - Insider Monkey
Will Cencora (COR) Beat Estimates Again in Its Next Earnings Report? - Yahoo Finance
Cencora to Announce Q3 2025 Results on August 6 with Live Webcast and Conference Call - MSN
Fund Update: FERGUSON WELLMAN CAPITAL MANAGEMENT, INC added 79,430 shares of CENCORA ($COR) to their portfolio - Quiver Quantitative
Here's What To Expect From Cencora's Next Earnings Report - Barchart.com
Cencora Q2 2025 slides: adjusted EPS jumps 16.3%, guidance raised By Investing.com - Investing.com Nigeria
Cencora Enhances Receivables Purchase Agreement for Liquidity - The Globe and Mail
Cencora Trading Volume Drops 40.8% to $385 Million Ranking 278th in Market - AInvest
Mizuho maintains Cencora stock rating on strong Walgreens data - Investing.com
$100 Invested In Cencora 10 Years Ago Would Be Worth This Much Today - Benzinga
Cencora's Insider Exodus: Risk or Opportunity? - AInvest
Cencora Executive VP & Chief Human Resources Officer Silvana Battaglia Sells 27% Of Holding - simplywall.st
Cencora, Inc.: Insider Selling and Overvaluation—Is This a Red Flag or Opportunity? - AInvest
Insider Sell: Silvana Battaglia Sells Shares of Cencora Inc (COR) - GuruFocus
Three fund managers share picks for tariff-resistant U.S. stocks - The Globe and Mail
$100 Invested In Cencora 5 Years Ago Would Be Worth This Much Today - Benzinga
Cencora Welcomes Lori J. Ryerkerk to Board of Directors - MSN
Cencora Inc. stock outperforms competitors on strong trading day - MarketWatch
Is Cencora Stock Outperforming The Dow? - Barchart.com
Is Cencora Stock Outperforming the Dow? - The Globe and Mail
Cencora Inc (COR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.42%
3.52%
자본화:
|
볼륨(24시간):